November 25, 2025

10x Genomics, Inc. (TXG) Stock Analysis: A Healthcare Innovator with Mixed Outlooks Amidst Analyst Ratings

10x Genomics, Inc. (NASDAQ: TXG), a prominent player in the healthcare sector, is making waves with its innovative life science technology products. Known for its cutting-edge platforms like Chromium, Visium,..

IDEAYA Biosciences, Inc. (IDYA): Analyst Ratings Suggest a 42.69% Potential Upside for This Biotech Innovator

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) has captured the attention of investors in the biotechnology sector with its promising pipeline of targeted therapeutics and strategic partnerships. As a precision medicine oncology..

MannKind Corporation (MNKD) Investor Outlook: Exploring an 83% Potential Upside and Promising Biopharmaceutical Developments

MannKind Corporation (NASDAQ: MNKD) has been capturing the attention of investors with its robust potential for growth in the biopharmaceutical sector. With a market capitalization of $1.58 billion, MannKind’s focus..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a 90% Potential Upside in the Healthcare Sector

Dynavax Technologies Corporation (NASDAQ: DVAX) presents a compelling opportunity for investors intrigued by the healthcare sector’s potential. With a market capitalization of $1.34 billion, this Emeryville, California-based biopharmaceutical company is..

Arcellx, Inc. (ACLX) Stock Analysis: A Biotech Gem with 50% Upside Potential

Arcellx, Inc. (NASDAQ: ACLX), a pioneering player in the biotechnology sector, is drawing significant attention from investors, thanks to its promising pipeline of immunotherapy candidates and a substantial 50.91% potential..

Celldex Therapeutics, Inc. (CLDX) Investor Outlook: Exploring a Potential 101.91% Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a biopharmaceutical company rooted in the biotechnology sector, is creating a buzz with its innovative therapeutic antibody developments aimed at treating severe inflammatory, allergic, and..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Envisioning a 256.99% Upside in Biotech Innovation

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) presents a compelling opportunity for individual investors navigating the dynamic biopharmaceutical sector. With a market capitalization of $793.75 million, this San Diego-based company is making..

GeneDx Holdings Corp. (WGS) Stock Analysis: A Diagnostic Powerhouse with Robust Revenue Growth

GeneDx Holdings Corp. (WGS), a key player in the healthcare sector, has been making waves in the diagnostics and research industry. With a market capitalization of $4.66 billion, GeneDx stands..

Artivion, Inc. (AORT) Stock Analysis: A Look at Its 12.89% Potential Upside in the Healthcare Sector

Artivion, Inc. (NASDAQ: AORT) has recently caught the attention of investors, thanks to its promising 12.89% potential upside. The Georgia-based medical device company has been making waves in the healthcare..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 30.97% Potential Upside in the Healthcare Sector

LifeStance Health Group, Inc. (NASDAQ: LFST) is making significant strides in the healthcare sector, focusing on mental health services across the United States. With a market capitalization of $2.52 billion,..

Astrana Health Inc. (ASTH) Investor Outlook: Exploring an 81.97% Upside Potential

Astrana Health Inc. (NASDAQ: ASTH) has emerged as an intriguing prospect in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $1.13 billion, this..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Uncovering a 149.69% Potential Upside in Biotech

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands as a beacon in the biotechnology sector, renowned for its focus on developing therapies for rare and ultra-rare genetic diseases. Headquartered in Novato, California,..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Exploring a 35.68% Upside with Robust Revenue Growth

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presents an intriguing opportunity for investors in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a current market capitalization of..

Immunocore Holdings plc (IMCR) Stock Analysis: A 65.13% Potential Upside Beckons Investors

Immunocore Holdings plc (NASDAQ: IMCR) stands at the forefront of biotechnology innovation, specializing in pioneering immunotherapies for the treatment of oncology, infectious, and autoimmune diseases. Headquartered in Abingdon, United Kingdom,..

BGM Group Ltd. (BGM): Investor Outlook Amidst Uncertain Valuation and Performance Metrics

BGM Group Ltd. (BGM), a healthcare sector player in the drug manufacturing industry, has caught the attention of investors despite its recent financial challenges. Based in Chengdu, China, the company..

NovoCure Limited (NVCR) Stock Analysis: Exploring a 98.95% Potential Upside

For investors seeking opportunities in the healthcare sector, NovoCure Limited (NASDAQ: NVCR) presents a compelling case with its significant potential upside of 98.95%, as indicated by analyst ratings. Specializing in..

Ardent Health, Inc. (ARDT) Stock Analysis: Navigating a 57% Potential Upside with Strong Buy Ratings

Ardent Health, Inc. (ARDT), a prominent player in the U.S. healthcare sector, focuses on delivering comprehensive medical services through its extensive network of hospitals and clinics. With a market capitalization..

Bausch Health Companies Inc. (BHC) Stock Analysis: Unveiling a 17% Potential Upside Amid a Challenging Market

Bausch Health Companies Inc. (NYSE: BHC), a prominent player in the healthcare sector with a specific focus on drug manufacturing, presents an intriguing opportunity for investors seeking exposure in the..

Liquidia Corporation (LQDA) Stock Analysis: A Biotech Powerhouse with 47.3% Potential Upside

Liquidia Corporation (NASDAQ: LQDA) has emerged as a noteworthy contender in the biotechnology sector, capturing investor attention with its remarkable revenue growth and substantial market cap of $2.6 billion. Based..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Exploring Growth Potential Amidst Volatility

Brookdale Senior Living Inc. (NYSE: BKD) stands as a prominent player within the medical care facilities industry, residing under the broad umbrella of the healthcare sector. With a market capitalization..

Search

Funds

November 25, 2025

Search

Funds

November 25, 2025

FTSE 100

Funds